Business

Sernova Advances Annual General Meeting and CEO Teleconference to Friday May 29

(via TheNewswire) LONDON, ONTARIO - TheNewswire - April 27, 2020 - Sernov...

articleSernova Biotherapeutics IncApril 27, 20205/company/sernova-corp/news/sernova-advances-annual-general-meeting-and-ceo-teleconference-to-friday-may-29
Sernova Advances Annual General Meeting and CEO Teleconference to Friday May 29

About this update from Sernova Biotherapeutics Inc

[{"type":"text","content":"Sernova Advances Annual General Meeting and CEO Teleconference to Friday May 29(via TheNewswire)\n \n \nLONDON, ONTARIO - TheNewswire - April 27, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH) announced today, with its continued COVID-19 vigilance, social gathering size restrictions in effect imposed by public health authorities and the now anticipated near term relaxation of certain COVID-19 public health-related restrictions, the Annual General Meeting (AGM) and CEO teleconference call originally scheduled for Thursday, April 30, 2020, has been adjourned to May 29, 2020, at 9:00 a.m. and 10:00 a.m. (Pacific Time), respectively. All other aspects of the AGM remain the same as published in the AGM materials, filed on www.sedar.com and available on www.sernova.com/investor/agm.\n\n\n \n\"Sernova has historically encouraged its shareholders to attend our AGM in person. Given the current restrictions imposed by the Canadian and provincial governments to reduce the spread of COVID-19, including restrictions on social gatherings, and travel, and feedback from our shareholders desiring to attend, we have decided to adjourn the AGM for 30 days to ensure the safety of everyone who may want to attend the meeting and to continue doing our part to help \"flatten the curve.\" We continue to monitor the COVID-19 situation actively and update our company policies accordingly to make proactive adjustments, and we appreciate our shareholders' support while we safely continue our operations,\" stated Dr. Philip Toleikis, President and CEO of Sernova.\n\n \n \nThe conference call details for the Annual Meeting of Shareholders are set out below. \n\n \n \nUS Toll-Free: + 1-877-366-0711\n\n \n \nCanada Toll-Free: + 1-866-627-1651\n\n \n \nInt'l Toll-Free: + 1-302-709-8446\n\n \n \nThe conference participant passcode is 109 985 50. Following the conference call, a recording will be available at www.sernova.com/agm\n\n \n \nABOUT SERNOVA'S CELL POUCH SYSTEM\n\n\n \nThe Cell Pouch(TM), as part of the Cell Pouch System, is a novel, proprietary, scalable, implantable macro- encapsulation device solution designed for the long-term survival and function of therapeutic cells. The device upon implantation is designed to incorporate with tissue, forming highly vascularized tissue chambers for the transplantation and function of therapeutic cells, whic...

More updates from Sernova Biotherapeutics Inc